{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:25:07Z","timestamp":1788261907384,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071462"],"award-info":[{"award-number":["82071462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Contactin-associated protein-2(CASPR2) antibody-associated autoimmune encephalitis(AE) is rare in children. This study aimed to report the clinical characteristics and long-term outcome of CASPR2 autoimmunity in children to expand the disease spectrum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Children who were hospitalized in our hospital with clinically suspected AE from May 2015 to April 2022 and underwent neuronal surface antibodies detections were retrospectively analyzed. Clinical data of patients with CASPR2 autoimmunity were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients who were positive for NMDAR-IgG, CASPR2-IgG, LGI1-IgG and IgLON5-IgG occupied 95.2%(119\/125),3.2%(4\/125),0.8%(1\/125) and 0.8%(1\/125), respectively.The median onset age of the 4 patients with CASPR2-IgG was 5.6 years. The most common symptoms were psychiatric symptoms\/abnormal behavior(3\/4) and sleep dysfunction(3\/4). One patient developed a phenotype of Rasmussen encephalitis(RE). Tumor was absent in our patients. Two patients showed abnormal findings on initial brain magnetic resonance imaging(MRI) scans. All the patients showed favorable response to immunotherapy except the patient with RE experienced recurrent symptoms who finally achieved remission after surgery. All the patients had a favorable long-term outcome at the last follow-up(33-58months).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CASPR2 autoimmunity may be the second most common anti-neuronal surface antibodies associated neurological disease in children. Psychiatric symptoms\/abnormal behavior and sleep disorder were common in children with CASPR2-associated AE. Tumor was rare in those patients. Most pediatric patients had a favorable long-term outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-024-01727-5","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T01:01:54Z","timestamp":1724634114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical characteristics and long-term outcome of CASPR2 antibody-associated autoimmune encephalitis in children"],"prefix":"10.1186","volume":"50","author":[{"given":"Donglei","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciliu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7752-6962","authenticated-orcid":false,"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"1140872","DOI":"10.3389\/fimmu.2023.1140872","volume":"14","author":"Q Kang","year":"2023","unstructured":"Kang Q, Liao H, Yang L, Fang H, Ning Z, Liao C, Gan S, Wu L. Clinical analysis of 173 pediatric patients with antibody-mediated autoimmune diseases of the central nervous system: a single-center cohort study. Front Immunol. 2023;14:1140872.","journal-title":"Front Immunol"},{"issue":"3","key":"1727_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41582-023-00776-4","volume":"19","author":"S Ramanathan","year":"2023","unstructured":"Ramanathan S, Brilot F, Irani SR, Dale RC. Origins and immunopathogenesis of autoimmune central nervous system disorders. Nat Rev Neurol. 2023;19(3):172\u201390.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1727_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25\u201336.","journal-title":"Ann Neurol"},{"issue":"9","key":"1727_CR4","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734\u201348.","journal-title":"Brain"},{"issue":"4","key":"1727_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","volume":"267","author":"M Boyko","year":"2020","unstructured":"Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G. Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol. 2020;267(4):1137\u201346.","journal-title":"J Neurol"},{"key":"1727_CR6","doi-asserted-by":"crossref","unstructured":"Cellucci T, Van Mater H, Graus F, Muscal E, Gallentine W, Klein-Gitelman MS, Benseler SM, Frankovich J, Gorman MP, Van Haren K et al. vol 7, e663, : Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient (2020). Neurol-Neuroimmunol 2020, 7(4).","DOI":"10.1212\/NXI.0000000000000663"},{"issue":"2","key":"1727_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.22427","volume":"70","author":"S Bigi","year":"2011","unstructured":"Bigi S, Fischer U, Wehrli E, Mattle HP, Boltshauser E, B\u00fcrki S, Jeannet PY, Fluss J, Weber P, Nedeltchev K, et al. Acute ischemic stroke in children versus young adults. Ann Neurol. 2011;70(2):245\u201354.","journal-title":"Ann Neurol"},{"key":"1727_CR8","doi-asserted-by":"publisher","first-page":"577598","DOI":"10.1016\/j.jneuroim.2021.577598","volume":"357","author":"L Zuliani","year":"2021","unstructured":"Zuliani L, Marangoni S, De Gaspari P, Rosellini I, Nosadini M, Fleming JM, De Riva V, Galloni E, Perini F, Frigo AC, et al. Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics. J Neuroimmunol. 2021;357:577598.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1727_CR9","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41598-023-28268-x","volume":"13","author":"L Wu","year":"2023","unstructured":"Wu L, Cai F, Zhuo Z, Wu D, Zhang T, Yang H, Fang H, Xiao Z. CASPR2 antibody associated neurological syndromes in children. Sci Rep. 2023;13(1):2073.","journal-title":"Sci Rep"},{"key":"1727_CR10","doi-asserted-by":"publisher","first-page":"736035","DOI":"10.3389\/fped.2021.736035","volume":"9","author":"C Tan","year":"2021","unstructured":"Tan C, Jiang Y, Zhong M, Hu Y, Hong S, Li X, Jiang L. Clinical features and outcomes in Pediatric Autoimmune Encephalitis Associated with CASPR2 antibody. Front Pediatr. 2021;9:736035.","journal-title":"Front Pediatr"},{"issue":"22","key":"1727_CR11","doi-asserted-by":"publisher","first-page":"e2290","DOI":"10.1212\/WNL.0000000000009523","volume":"94","author":"S Syrbe","year":"2020","unstructured":"Syrbe S, Stettner GM, Bally J, Borggraefe I, Bien CI, Ferfoglia RI, Huppke P, Kern J, Polster T, Probst-Muller E, et al. CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension. Neurology. 2020;94(22):e2290\u2013301.","journal-title":"Neurology"},{"key":"1727_CR12","doi-asserted-by":"publisher","first-page":"577008","DOI":"10.1016\/j.jneuroim.2019.577008","volume":"335","author":"M Nosadini","year":"2019","unstructured":"Nosadini M, Toldo I, Tascini B, Bien CG, Parmeggiani L, De Gaspari P, Zuliani L, Sartori S. LGI1 and CASPR2 autoimmunity in children: systematic literature review and report of a young girl with Morvan syndrome. J Neuroimmunol. 2019;335:577008.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"1727_CR13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/jnnp-2022-329195","volume":"93","author":"S Matricardi","year":"2022","unstructured":"Matricardi S, Casciato S, Bozzetti S, Mariotto S, Stabile A, Freri E, Deleo F, Sartori S, Nosadini M, Pappalardo I, et al. Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy. J Neurol Neurosur Ps. 2022;93(11):1194\u2013201.","journal-title":"J Neurol Neurosur Ps"},{"issue":"3","key":"1727_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.25310","volume":"84","author":"AS Lopez-Chiriboga","year":"2018","unstructured":"Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, et al. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018;84(3):473\u201380.","journal-title":"Ann Neurol"},{"issue":"2","key":"1727_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14581\/jer.14012","volume":"4","author":"SY Kim","year":"2014","unstructured":"Kim SY, Choi SA, Ryu HW, Kim H, Lim BC, Hwang H, Chae JH, Choi J, Kim KJ, Hwang YS, et al. Screening autoimmune anti-neuronal antibodies in Pediatric patients with suspected autoimmune encephalitis. J Epilepsy Res. 2014;4(2):55\u201361.","journal-title":"J Epilepsy Res"},{"key":"1727_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.005","volume":"281","author":"JS Sunwoo","year":"2015","unstructured":"Sunwoo JS, Lee ST, Byun JI, Moon J, Shin JW, Jeong DE, Lee GH, Jeong SH, Shin YW, Jung KH, et al. Clinical manifestations of patients with CASPR2 antibodies. J Neuroimmunol. 2015;281:17\u201322.","journal-title":"J Neuroimmunol"},{"key":"1727_CR17","doi-asserted-by":"publisher","first-page":"175628642096946","DOI":"10.1177\/1756286420969462","volume":"13","author":"P Liu","year":"2020","unstructured":"Liu P, Bai M, Yan X, Ren K, Ding J, Zhao D, Li H, Yan Y, Guo J. Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report. Ther Adv Neurol Disord. 2020;13:1756286420969462.","journal-title":"Ther Adv Neurol Disord"},{"key":"1727_CR18","doi-asserted-by":"publisher","first-page":"652864","DOI":"10.3389\/fimmu.2021.652864","volume":"12","author":"X Qin","year":"2021","unstructured":"Qin X, Yang H, Zhu F, Wang Q, Shan W. Clinical character of CASPR2 autoimmune encephalitis: a multiple Center Retrospective Study. Front Immunol. 2021;12:652864.","journal-title":"Front Immunol"},{"issue":"2","key":"1727_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1684\/epd.2016.0829","volume":"18","author":"B Samanci","year":"2016","unstructured":"Samanci B, Tekturk P, Tuzun E, Erdag E, Kinay D, Yapici Z, Baykan B. Neuronal autoantibodies in patients with Rasmussen\u2019s encephalitis. Epileptic Disord. 2016;18(2):204\u201310.","journal-title":"Epileptic Disord"},{"issue":"6","key":"1727_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/ane.13712","volume":"146","author":"C Tang","year":"2022","unstructured":"Tang C, Yang W, Luan G. Progress in pathogenesis and therapy of Rasmussen\u2019s encephalitis. Acta Neurol Scand. 2022;146(6):761\u20136.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1727_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13180","volume":"24","author":"CG Bien","year":"2017","unstructured":"Bien CG, Mirzadjanova Z, Baumgartner C, Onugoren MD, Grunwald T, Holtkamp M, Isenmann S, Kermer P, Melzer N, Naumann M, et al. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome. Eur J Neurol. 2017;24(1):175\u201386.","journal-title":"Eur J Neurol"},{"key":"1727_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3389\/fimmu.2018.00703","volume":"9","author":"CG Bien","year":"2018","unstructured":"Bien CG. Overinterpretation and overtreatment of low-titer antibodies against Contactin-Associated Protein-2. Front Immunol. 2018;9:703.","journal-title":"Front Immunol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-024-01727-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T01:08:08Z","timestamp":1724634488000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-024-01727-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1186\/s13052-024-01727-5","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee at the Xiangya Hospital of Central South University and all methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all patients\u2019 parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all patients\u2019 parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}